Recro Pharma, Inc. (REPH)

[RealGenius]

505(2)(b) program for development of non-opiod post surgical pain drug.

Really, they are just reformulating dexmedetomidine. This is a great non-hypnotic anxiolytic with a 30% narcotic sparing effect. [Established IV medication with lots of data out there]. But as a solo agent for pain? Ehh. This will never be a big sellor even if they demonstrate efficacy. Should be exploring as a pre-op med.